top
biolitec pharma head and neck cancer
head and neck cancer, neck squamous cell carcionoma, Plattenepitelkarzinom,foscanContactHome
photodynamic therapy		 head and neck cancer, neck squamous cell carcionoma, Plattenepitelkarzinom,foscan
Foscan
head and neck cancer		 head and neck cancer, neck squamous cell carcionoma, Plattenepitelkarzinom,foscan
head and neck cancer, neck squamous cell carcionoma, Plattenepitelkarzinom,foscan
head and neck cancer, neck squamous cell carcionoma, Plattenepitelkarzinom,foscan
News
 

CeramOptec
biolitec
WE ARE MACMILLAN Cancer Support

facing life

killing_cancer

News

This section of the site is intended for members of the media and contains information provided by biolitec pharma in the UK.

22/09/2011

biolitec unterstützt Mouth Cancer Foundation beim 6. Mouth Cancer Walk [mehr]

biolitec supports Mouth Cancer Foundation for 6th Mouth Cancer Walk [more]

15/11/2010

Foscan® helpt 68% uitbehandelde hoofdhalskankerpatiënten [more]

12/04/2010



Head and neck cancer patients who do not respond to other treatment benefit from photodynamic therapy with Foscan® [more]

Austherapierte Patienten mit Kopf-Hals-Krebs profitieren von Photodynamischer Therapie mit Foscan® [mehr]

29/03/2010

PDT medication Foscan® now reimbursed in the Netherlands and included in the list of high-cost medicines by Dutch Healthcare Authority – Head and neck cancer patients can now temporarily be treated free of charge at medical centers in the Netherlands [more]

Krebs-Medikament Foscan® wird in den Niederlanden erstattet und ist in staatliche Liste der kostenintensiven Medikamente aufgenommen – Patienten mit Hals- oder Kopfkrebs können sich jetzt vorübergehend kostenlos in holländischen Kliniken behandeln lassen [mehr]
 


Print Version | Top


© 2010 biolitec pharma ltd    All Rights Reserved.